XOMA Acquires Kinnate Biopharma: Advancing Precision Oncology
1 Mins read
XOMA, a prominent biotechnology royalty aggregator, has announced its plans to acquire clinical-stage precision oncology company, Kinnate Biopharma. This strategic acquisition aims…